triptolide has been researched along with Diabetes Mellitus, Type 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, YS; Liu, LQ; Ma, RX; Xu, Y; Zhang, J | 1 |
1 other study(ies) available for triptolide and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
[Triptolide combined with irbesartan synergistically blocks podocyte injury in a type 2 diabetes rat model].
Topics: Animals; Biphenyl Compounds; Bone Morphogenetic Protein 7; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diterpenes; Epoxy Compounds; Irbesartan; Male; Phenanthrenes; Podocytes; Rats; Rats, Wistar; Tetrazoles; Transforming Growth Factor beta1 | 2012 |